Related Experiment Video
Updated: Feb 10, 2026

Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System
Published on: March 20, 2016
Past, current and future approaches to querying MAPK pathway activation: status and clinical implications
Ken Cn Chang1, Matthew J Marton1
1Molecular Biomarkers & Diagnostics, Merck & Co, Inc., Rahway, NJ, USA.
Abstract:
MAPK pathway activation related to cancer development has drawn a great deal of attention in the field of personalized medicine in recent years. Many different approaches and assays have been developed to query the activation of this pathway and to develop life-saving treatments. The goal of this review article is threefold. First, to provide a brief overview of the many mutation assays that have been used to detect MAPK pathway activation, and to compare pros and cons of these assay platforms. Second, to focus on one custom-designed multiplexing mutation assay that is currently used to support an ongoing clinical trial and to show the novel features of this assay and its relevance in addressing unmet clinical needs. Third, to provide future perspectives of these MAPK pathway gene mutation detection efforts and to suggest how what we have learned from past and current approaches should guide future developments.
Insights
This review examines MAPK pathway activation assays for personalized cancer medicine. It highlights a novel multiplexing assay for clinical trials and discusses future directions in mutation detection.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Mitogen-activated protein kinase (MAPK) pathway activation is a key driver in many cancers, making it a significant target for personalized medicine.
- Detecting MAPK pathway activation is crucial for developing targeted therapies and improving patient outcomes.
- Numerous mutation assays have been developed to identify alterations within the MAPK pathway.
Purpose of the Study:
- To provide an overview and comparison of various mutation assays used for detecting MAPK pathway activation.
- To detail a custom-designed multiplexing mutation assay utilized in an ongoing clinical trial, emphasizing its novel features and clinical relevance.
- To offer future perspectives on MAPK pathway gene mutation detection, guiding subsequent research and development.
Main Methods:
- Review of existing literature on MAPK pathway mutation assays.
- Analysis of the design, performance, and advantages/disadvantages of different assay platforms.
- In-depth examination of a specific custom multiplexing assay, including its application in a clinical trial setting.
Main Results:
- Comparison of diverse mutation assay platforms, detailing their respective strengths and limitations.
- Demonstration of the innovative aspects and clinical utility of a custom multiplexing assay supporting a current clinical trial.
- Identification of key learnings from past and current mutation detection strategies.
Conclusions:
- Mutation assays are vital tools for understanding MAPK pathway activation in cancer.
- Novel multiplexing assays offer significant advantages for clinical applications and personalized treatment strategies.
- Future developments in MAPK pathway mutation detection should leverage insights from current technologies to address unmet clinical needs.
Related Concept Videos
MAPK Signaling Cascades
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Marcia's Theory of Identity Status
Electrical Current
Other Glycolytic Pathways
Respiration Pathways

